| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/06/2004 | US6673375 Mostly comprising sodium metasilicate (pentahydrate) and shows nonspecific immunostimulating activity in plants and animals |
| 01/06/2004 | US6673373 Antifungal formulation and the methods for manufacturing and using the same |
| 01/06/2004 | US6673370 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| 01/06/2004 | US6673368 Colonic motor dysfunction remedies comprising aminothiazole derivatives as active ingredients |
| 01/06/2004 | US6673367 High speed initial onset of effect and prolonged duration falls rapidly at end of dosing interval so as not to affect the appetite or sleep of patient; side effect reduction |
| 01/06/2004 | US6673365 Administering hooc-ch2-(r)-cgl-aze-pab where cgl is cyclohexylglycine, aze is azetidine-2-carboxylic acid, and pab is 1-amidino-4-aminomethylbenzene |
| 01/06/2004 | US6673363 Transdermal and topical administration of local anesthetic agents using basic enhancers |
| 01/06/2004 | US6673358 Wet wipes containing a mono alkyl phosphate |
| 01/06/2004 | US6673337 Compositions containing alpha-2-adrenergic agonist components |
| 01/06/2004 | US6673336 Comprising an inorganic pigment and an active substance based on organic compounds being covalently bound through a group 3b,4a,4b,5b,6b spacer group to the inorganic pigment; sunscreen agents |
| 01/06/2004 | US6673054 Vitamin incorporated into thermoplastic material |
| 01/06/2004 | CA2341803C Controlled release formulation of divalproex sodium |
| 01/06/2004 | CA2309717C Treatment of scar tissue using lipoic acid |
| 01/06/2004 | CA2301990C New substitute dimerized derivatives, process for preparing them, and pharmaceutical compounds containing them |
| 01/06/2004 | CA2293712C Benzo(5,6)cycloheptapyridine cyclic ureas and lactams useful as farnesyl protein transferase inhibitors |
| 01/06/2004 | CA2292629C Composition comprising 5-¬4-¬2-(n-methyl-n-2-pyridyl)amino)ethoxy|benzyl|thiazolidine-2,4-dione |
| 01/06/2004 | CA2285891C Triazole antifungal agents |
| 01/06/2004 | CA2253870C Inhibition of matrix metalloproteases by substituted phenalkyl compounds |
| 01/06/2004 | CA2247063C Treatment of macular edema |
| 01/06/2004 | CA2232008C Use of epinastine for the treatment of pain |
| 01/06/2004 | CA2227761C Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers |
| 01/06/2004 | CA2223588C Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 01/06/2004 | CA2145248C Pharmaceutical compositions containing time-released orally taken trimetazidine |
| 01/06/2004 | CA2119762C Therapeutic inhibition of platelet aggregation by nucleophile-nitric oxide complexes and derivatives thereof |
| 01/06/2004 | CA2106895C Combating fish parasites |
| 01/02/2004 | EP1375662A1 A novel polypeptide compose substance for promoting blood and blood vessel cell growth |
| 01/02/2004 | EP1375516A2 Method of production of a recombinant polypeptide of the LSR receptor |
| 01/02/2004 | EP1375509A1 Use of a sapogenin, or a natural extract containing the same, for the treatment of oligoseborrheic dry skin |
| 01/02/2004 | EP1375508A1 N6-substituted adenosine analogues and their use as pharmaceutical agents |
| 01/02/2004 | EP1375503A1 Dioxino derivatives and their use as dopanine agonists |
| 01/02/2004 | EP1375499A1 Process for the production of 2-(5-methyl-4-oxazolyl)ethanol derivatives |
| 01/02/2004 | EP1375497A1 Magnesium salt of s-omeprazole |
| 01/02/2004 | EP1375496A1 N-aryl-substituted cyclic amine derivative and medicine containing the same as active ingredient |
| 01/02/2004 | EP1375486A1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
| 01/02/2004 | EP1375482A1 Benzamidine derivative |
| 01/02/2004 | EP1375472A1 Benzene compound and salt thereof |
| 01/02/2004 | EP1375465A1 Cyclooctanone derivative and cyclodecanone derivative, and use thereof |
| 01/02/2004 | EP1374952A1 Use of flumazenil in developing a drug for the treatment of alcohol dependence |
| 01/02/2004 | EP1374923A2 Porous implants with antibiotic coating, their preparation and use |
| 01/02/2004 | EP1374912A1 Use of metaloporphyrins for treatment of arteriosclerotic lesions |
| 01/02/2004 | EP1374908A2 Polymer-drug conjugates comprising hydrazide linkers |
| 01/02/2004 | EP1374907A2 Drug transport and delivery system |
| 01/02/2004 | EP1374906A1 A process for the preparation of piroxicam: beta-cyclodextrin inclusion compounds |
| 01/02/2004 | EP1374904A1 Preparation containing polymethyl-siloxane for nails, cartilage, bone joint, muscle and tendon disorders |
| 01/02/2004 | EP1374903A1 Pharmaceutical composition for the prevention of the development and progression of mycotic skin surface diseases |
| 01/02/2004 | EP1374902A1 Remedies for inflammatory bowel diseases |
| 01/02/2004 | EP1374901A1 Graft rejection suppressors |
| 01/02/2004 | EP1374899A1 Remedies for post-traumatic stress disorder |
| 01/02/2004 | EP1374890A2 Thrombopoietin compositions for increasing circulating platelets |
| 01/02/2004 | EP1374884A1 Proteotoxin neutralizer |
| 01/02/2004 | EP1374882A1 Use of mixtures of active ingredients for the manufacture of a medicament for the treatment of rheumatoid arthritis |
| 01/02/2004 | EP1374875A2 Pharmaceutical compositons comprising arsenic for the treatment of myelodysplastic syndrome |
| 01/02/2004 | EP1374874A2 Liquid antacid compositions |
| 01/02/2004 | EP1374873A1 The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy |
| 01/02/2004 | EP1374872A1 Pharmaceutical preparations comprising a combination of at least one representative of antibiotics and one of antiphlogistics, process for manufacturing, and use thereof |
| 01/02/2004 | EP1374871A1 Crystalline isoxazole derivative and medical preparation thereof |
| 01/02/2004 | EP1374870A1 Medication for the treatment or prevention of migraine |
| 01/02/2004 | EP1374869A1 Novel use of arylethene sulfonamide derivative |
| 01/02/2004 | EP1374868A1 Remedies and/or preventives for diabetic ischemic heart diseases |
| 01/02/2004 | EP1374867A1 Use of chloroquine, hydroxychloroquine and 4 amino-quinolinic derivatives to obtain a drug for the anti retroviral therapy, active towards hiv sensitive strains and towards hiv strains which are resistant to both nucleosidic and non-nucleosidic reverse transcriptase inhibitors and to proteases inhibitors |
| 01/02/2004 | EP1374865A1 Use of R,S-(+/-)-alpha-lipoic acid, R(+)-alpha-lipoic acid or S-(-)-alpha-lipoic acid in reduced or oxidised form, or their metabolites as well as their salts, esters or amides, for the treatment of hearing disorders |
| 01/02/2004 | EP1374864A1 Amphiphilic taxane compositions |
| 01/02/2004 | EP1374863A1 Amino acid compositions for ameliorating liver failure |
| 01/02/2004 | EP1374862A2 Use of a substance influencing the degree of phosphorylation of BAD for the treatment of atherosclerosis |
| 01/02/2004 | EP1374861A1 External preparations for treating dermatoses |
| 01/02/2004 | EP1374859A1 Solid pharmaceutical composition comprising tilidine hydrochloride |
| 01/02/2004 | EP1374856A1 Oily thixotropic nasal spray |
| 01/02/2004 | EP1374855A1 Medicinal solutions |
| 01/02/2004 | EP1374854A1 Delayed release pharmaceutical composition, method of production and use of said composition |
| 01/02/2004 | EP1374853A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374852A1 Cosmetic and/or dermatological Composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374851A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374850A1 Cosmetic and/or dermatological composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374849A1 Cosmetic and/or dermatological use of a composition containing at least one oxidation-sensitive hydrophilic active stabilised by at least one polymer or copolymer of maleic anhydride |
| 01/02/2004 | EP1374847A1 Stable hydroalcoholic compositions |
| 01/02/2004 | EP1374832A1 Cosmetics to promote maturation of cornified envelope and method for treatment |
| 01/02/2004 | EP1374693A2 Method for preventing decrease of breast milk amount in mammals |
| 01/02/2004 | EP1373905A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents |
| 01/02/2004 | EP1373543A2 Method for producing pectin hydrolysis products |
| 01/02/2004 | EP1373535A2 Improved gene expression |
| 01/02/2004 | EP1373504A2 Mammalian tribbles signaling pathways and methods and reagents related thereto |
| 01/02/2004 | EP1373494A2 Succinimide and maleimide derivatives and their use as topoisomerase ii catalytic inhibitors |
| 01/02/2004 | EP1373489A2 Human dual specificity protein phosphatase 7-like protein |
| 01/02/2004 | EP1373396A1 Highly nucleated thermoplastic articles |
| 01/02/2004 | EP1373368A1 Compounds for a controlled release of active compounds |
| 01/02/2004 | EP1373366A2 Multi-arm block copolymers as drug delivery vehicles |
| 01/02/2004 | EP1373317A2 Nuclear hormone receptor ligand binding domains |
| 01/02/2004 | EP1373316A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373315A2 Nuclear hormone receptor ligand binding domain |
| 01/02/2004 | EP1373313A2 Proteins and nucleic acids encoding same |
| 01/02/2004 | EP1373306A2 Cytoskeletion-associated proteins |
| 01/02/2004 | EP1373300A2 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain |
| 01/02/2004 | EP1373298A1 A composition containing novel compound corniculatonin having antifungi properties and a process for preparing the same |
| 01/02/2004 | EP1373293A1 Steap-related protein |
| 01/02/2004 | EP1373290A1 Pesticidal spinosyn derivatives |
| 01/02/2004 | EP1373289A1 9-amino-14-membered macrolide derived from leucomycin |
| 01/02/2004 | EP1373287A1 Process for obtaining lignan, pharmaceutical compositions and uses thereof |
| 01/02/2004 | EP1373275A2 Highly purified and crystalline form of harringtonine |
| 01/02/2004 | EP1373271A1 Indole derivatives having an inhibitory effect on protein kinases |
| 01/02/2004 | EP1373269A1 Jun kinase inhibitors |